disease

Hepatitis

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Hepatitis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

845Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

Summary

Hepatitis is a disease characterized by neurodegeneration research. Key relationships include: therapeutic target, activates, associated with. Associated with Aging, Als, Alzheimer. Connected to 690 entities in the SciDEX knowledge graph.

View on Wiki →

Disease Info

Associated Genes	OCLN, TGFB1, STAT3, NSD2, GAIN, DNA, PAH, IL6
KG Connections	837 knowledge graph edges
Databases	OMIM Orphanet ClinicalTrials PubMed

Wiki Pages (20)

Knowledge base pages for this entity

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Pathway Diagram

graph TD
    Hepatitis["Hepatitis"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
    Hepatitis["Hepatitis"] -->|"contributes to"| Pyroptosis["Pyroptosis"]
    Hepatitis["Hepatitis"] -->|"contributes to"| Necroptosis["Necroptosis"]
    Hepatitis["Hepatitis"] -->|"contributes to"| Apoptosis_1["Apoptosis"]
    Hepatitis["Hepatitis"] -.->|"inhibits"| Cholesterol["Cholesterol"]
    Hepatitis["Hepatitis"] -->|"contributes to"| Ferroptosis["Ferroptosis"]
    SRPK1["SRPK1"] -->|"therapeutic target"| Hepatitis["Hepatitis"]
    FASN["FASN"] -.->|"inhibits"| Hepatitis["Hepatitis"]
    BAX["BAX"] -.->|"inhibits"| Hepatitis["Hepatitis"]
    ALOX15["ALOX15"] -.->|"inhibits"| Hepatitis["Hepatitis"]
    style Hepatitis fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (191)

Target	Relation	Type	Str
Inflammation	associated_with	disease	1.00
Inflammation	activates	disease	1.00
Autophagy	activates	pathway	1.00
Als	associated_with	disease	0.95
Inflammation	inhibits	disease	0.85
Inflammation	therapeutic_target	disease	0.85
Cholesterol	therapeutic_target	pathway	0.80
Mtor	therapeutic_target	pathway	0.80
Autophagy	therapeutic_target	pathway	0.80
Cholesterol	activates	pathway	0.80
Unfolded Protein Response	therapeutic_target	pathway	0.80
Fatty Liver	activates	disease	0.75
Fatty Liver	associated_with	disease	0.75
Apoptosis	contributes_to	pathway	0.70
Immune Response	regulates	pathway	0.70
Oxidative Stress	activates	pathway	0.70
Lipid Metabolism	activates	pathway	0.70
Mtor	activates	pathway	0.70
Mapk	therapeutic_target	pathway	0.70
Lipid Metabolism	regulates	pathway	0.70
Ferroptosis	therapeutic_target	pathway	0.70
Lipid Metabolism	therapeutic_target	pathway	0.70
Epigenetic	therapeutic_target	pathway	0.70
Complement	therapeutic_target	pathway	0.70
Autophagy	implicated_in	pathway	0.70
Lipid Metabolism	implicated_in	pathway	0.70
Ferroptosis	activates	pathway	0.70
Lipid Metabolism	associated_with	pathway	0.70
Oxidative Stress	associated_with	pathway	0.70
Oxidative Stress	inhibits	pathway	0.70
Apoptosis	inhibits	pathway	0.70
Autoimmune	associated_with	disease	0.65
Carcinoma	associated_with	disease	0.65
Apoptosis	associated_with	pathway	0.65
Als	activates	disease	0.65
Fatty Liver	therapeutic_target	disease	0.65
Obesity	associated_with	disease	0.65
Apoptosis	therapeutic_target	pathway	0.60
Pyroptosis	contributes_to	pathway	0.60
Necroptosis	contributes_to	pathway	0.60
Cholesterol	inhibits	pathway	0.60
Ferroptosis	contributes_to	pathway	0.60
Akt	regulates	pathway	0.60
Circadian Rhythm	regulates	pathway	0.60
Wnt	activates	pathway	0.60
Tgf-Β	activates	pathway	0.60
Inflammasome	activates	pathway	0.60
Mitophagy	activates	pathway	0.60
Akt	activates	pathway	0.60
Epigenetic	activates	pathway	0.60

Incoming (654)

Source	Relation	Type	Str
Fibrosis	associated_with	disease	1.00
GENES	activates	gene	1.00
Cancer	associated_with	disease	1.00
Carcinoma	associated_with	disease	1.00
Cirrhosis	associated_with	disease	1.00
INFLAMMATION	activates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
CANCER	associated_with	gene	1.00
INFLAMMATION	inhibits	gene	1.00
Als	inhibits	disease	1.00
Infection	associated_with	disease	1.00
Als	therapeutic_target	disease	1.00
GENES	therapeutic_target	gene	0.95
Als	associated_with	disease	0.95
AUTOPHAGY	activates	gene	0.95
CANCER	activates	gene	0.95
Hepatocellular Carcinoma	associated_with	disease	0.95
Fibrosis	therapeutic_target	disease	0.95
Fibrosis	biomarker_for	disease	0.95
BAX	inhibits	gene	0.85
TNF	inhibits	gene	0.85
GENES	inhibits	gene	0.85
MTOR	therapeutic_target	gene	0.85
GENES	associated_with	gene	0.85
MTORC1	therapeutic_target	gene	0.85
AUTOPHAGY	therapeutic_target	gene	0.85
CANCER	therapeutic_target	gene	0.85
FERROPTOSIS	therapeutic_target	gene	0.85
OXIDATIVE STRESS	activates	gene	0.85
OXIDATIVE STRESS	associated_with	gene	0.85
CYTOKINES	associated_with	gene	0.85
Liver Cancer	associated_with	disease	0.85
MITOCHONDRIA	therapeutic_target	gene	0.85
KEAP1	activates	gene	0.75
NRF2	activates	gene	0.75
Diabetes	associated_with	disease	0.75
AMPK	activates	gene	0.75
P62	activates	gene	0.75
AKT	activates	gene	0.75
Tumor	associated_with	disease	0.75
AMPK	therapeutic_target	gene	0.75
MIRNAS	therapeutic_target	gene	0.75
PI3K	activates	gene	0.75
TLR4	activates	gene	0.75
MICRORNAS	therapeutic_target	gene	0.75
CLDN1	therapeutic_target	gene	0.75
PTGS2	therapeutic_target	gene	0.75
LIPOPHAGY	activates	gene	0.75
CANCER	expressed_in	gene	0.75

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Hepatitis

Understanding Entity Pages

Summary

Wiki Pages (20)

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

nimodipine-als

rasagiline

APOC4 — Apolipoprotein C-IV

omega-3-fatty-acids-neurodegeneration

Melatonin for Tauopathy: Comprehensive Evidence Synthesis

Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Lateral Sclerosis

Sulforaphane and Nrf2 Activation for Neuroprotection

deferiprone-neurodegeneration

Niemann-Pick Disease Type C (NPC)

A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

PMN310 Anti-Amyloid for AD (NCT06750432)

vitamin-d-therapy-neurodegeneration

metal-ion-synuclein-mitochondria-axis-parkinsons

Curcumin for Neurodegeneration

IGF-1 Signaling Pathway in Neurodegeneration

Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT06223360)